Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Bang bang

<< Previous

Bullboard Posts

Next >>

Comment by SPCEO1on May 13, 2021 10:30am

63 Views

Post# 33191119

RE:RE:RE:Bang bang

I am not sure anyone was able to log in as a shareholder.

qwerty22 wrote: Im logged in as guest. Can somebody ask for a mini update on the cancer trial? Enrolment numbers etc?

SPCEO1 wrote: Hopefully, they are tearing down

palinc2000 wrote: There appears to be a demolition team in the room!!!